Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 12 min 58 sec ago

Roche cancer immunotherapy Tecentriq wins EU approval

September 23, 2017 - 2:51pm
ZURICH (Reuters) - Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.

Novelion's Aegerion resolves U.S. drug probes for $40 million

September 23, 2017 - 6:54am
BOSTON (Reuters) - Aegerion Pharmaceuticals Inc will plead guilty to two misdemeanors and pay $40.1 million to resolve investigations into its marketing and sales of an expensive cholesterol drug, U.S. authorities said on Friday.

Novelion's Aegerion resolves U.S. drug probes for $40 mln

September 23, 2017 - 2:55am
BOSTON (Reuters) - Aegerion Pharmaceuticals Inc will plead guilty to two misdemeanors and pay $40.1 million to resolve investigations into its marketing and sales of an expensive cholesterol drug, U.S. authorities said on Friday.

FDA declines to approve J&J arthritis drug sirukumab

September 23, 2017 - 2:53am
(Reuters) - The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday.

Cost of healthy foods may explain heart risks linked to ‘food deserts’

September 23, 2017 - 2:14am
(Reuters Health) - Living in an area with little access to fresh and nutritious foods has been linked to high heart disease risk, but a new study suggests that it’s the inability to afford a healthy diet, rather than access, that’s to blame.

Some youth football drills raise head-impact risk more than others

September 23, 2017 - 12:40am
(Reuters Health) - Several youth football drills expose young athletes to head impacts more frequently and more roughly than others, according to a U.S. study that followed 10- and 11-year-old players for a full season.

Native American tribe moves to dismiss Allergan patent case

September 23, 2017 - 12:34am
(Reuters) - A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV challenging the patents.

Resistance exercise linked to reduced anxiety

September 22, 2017 - 11:19pm
(Reuters Health) - People who do resistance exercises like weight lifting may experience less anxiety than people who don’t workout, a research review suggests

Cholesterol drug maker pays $4.1 million to settle fraud charges: SEC

September 22, 2017 - 10:56pm
WASHINGTON (Reuters) - Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics, will pay $4.1 million to settle charges it misled investors about how many patients purchased Juxtapid, a drug used to treat a genetic condition that leads to high cholesterol, the top U.S. securities regulator said on Friday.

Intensive rehab can help military patients work after brain injuries

September 22, 2017 - 10:32pm
(Reuters Health) - Four in five military service members who suffer brain injuries may be able to return to military or civilian work after they get treatment at inpatient rehabilitation facilities, a UK study suggests.

India's drug prices regulator calls for better oversight of private hospitals

September 22, 2017 - 6:26pm
MUMBAI (Reuters) - India's drug pricing authority called for better regulation of the country's massive private healthcare industry on Friday to ensure government efforts to cut prices benefit patients.

Japan health minister to consider U.S. drug firms' views in pricing overhaul

September 22, 2017 - 3:14pm
TOKYO (Reuters) - Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end a drastic revision of its drug-pricing system, aimed at reining in medical spending and cutting the public burden, the health minister said on Friday.

Roche receives EU approval for Gazyvaro, European approval for Actemra

September 22, 2017 - 11:02am
ZURICH (Reuters) - Roche said it has received European approval for its Actemra medication in giant cell arteritis (GCA), the Swiss drugmaker said on Friday.

BYU lifts decades-long ban on caffeinated soft drink sales

September 22, 2017 - 5:39am
(Reuters) - Brigham Young University has ended a 60-year ban on the sale of caffeinated soft drinks at its flagship campus in Provo, Utah, the Mormon Church-owned school said on Thursday.

A daily half hour's exercise could prevent 1 in 12 early deaths, study shows

September 22, 2017 - 4:33am
LONDON, Sept 22 (Reuters) - People who exercise five days a week for 30 minutes significantly reduce their risk of dying early and of developing heart disease, even if a sports club or gym is not an option, according to a new international study.

Versartis growth hormone drug fails key study, shares sink

September 22, 2017 - 3:30am
(Reuters) - Versartis Inc said its experimental drug for the treatment of growth hormone deficiency in children did not meet the main goal of a late-stage study, sending its shares tanking 85 percent.

Dozens of alcohol-flavored tobacco products may lure teens

September 22, 2017 - 2:14am
(Reuters Health) - Nearly 50 alcohol-flavored tobacco product lines are marketed by more than 400 tobacco brands in the United States and these products may especially attract teens, luring them into tobacco addiction, according to a new study.

U.S. safety board says train crash engineers had undiagnosed sleep disorder

September 22, 2017 - 1:46am
WASHINGTON (Reuters) - The engineers in two New York City area commuter train crashes suffered from sleep apnea that had not been diagnosed, the U.S. National Transportation Safety Board said on Thursday.

State funding changes in spotlight in Republican healthcare bill

September 22, 2017 - 1:03am
WASHINGTON (Reuters) - Republican leaders sought to nail down the final votes needed to pass what U.S. Vice President Mike Pence on Thursday called their "last best chance" to repeal Obamacare while a new analysis underscored how Democratic-leaning states stand to lose large amounts of federal funding under the legislation.

Stopping antidepressants tied to increased relapse risk

September 22, 2017 - 12:54am
(Reuters Health) - People taking antidepressants for anxiety, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are more likely to relapse when they stop using these drugs than when they remain on medication, a research review confirms.